On January 28, 2024, Neuralink, Elon Musk’s neurotechnology company, implanted an implant in the human brain for the first time. The patient is already recovering. The results already look promising. About this entrepreneur reported on X (formerly Twitter).
Neuralink’s first product is called Telepathy. With its help, patients will be able to control their phones and computers with their thoughts.
Neuralink received approval from an independent review board in September 2023 for the first-in-human clinical trial of its brain implant chip. The company then began recruiting volunteers among patients with paralysis due to cervical spinal cord injury or amyotrophic lateral sclerosis.
- In May, the U.S. Food and Drug Administration allowed Neuralink to test brain chips in humans.
- In August, the company raised $280 million in a D round investment. Prior to this round, the brain chip developer was valued at $5 billion.
Author:
Karina Pardaeva
Source: RB
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
